» Articles » PMID: 25328300

Molecular Screening of Lysyl Oxidase G473A Polymorphism in Oral Submucous Fibrosis

Overview
Date 2014 Oct 21
PMID 25328300
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate the presence of lysyl oxidase (LOX) G473A polymorphism in group 1 {Oral submucous fibrosis (OSMF) patients}, group 2 (betel quid chewers without OSMF) and group 3 (healthy individuals).

Materials And Methods: A total of 60 patients were taken for the study, which included 20 OSMF patients (group 1), 20 betel quid chewers without OSMF (group 2) and 20 healthy individuals without OSMF and betel quid chewing habit (group 3). DNA was isolated using Qiagen kit. The isolated DNA was quantified using spectroscopic methods. Polymerase chain reaction (PCR) was carried out at annealing temperature of 67(o) C. PCR amplification was checked on 2% agarose gel. Further, the amplified PCR products were subjected to automated DNA sequencer, to assess LOX G473A polymorphism.

Results: The gene sequence data generated from the automated DNA sequencer was received as colored electropherograms. These gene-sequencing results did not show LOX G473A polymorphism in any of the 3 groups.

Conclusion: In our study, gene-sequencing results did not show LOX G473A polymorphism in OSMF patients. Since only one study in the literature has shown the association of LOX gene polymorphism and OSMF patients, we conclude that further studies are required to unveil the role of LOX gene polymorphism in OSMF.

Citing Articles

Understanding the molecular mechanism associated with reversal of oral submucous fibrosis targeting hydroxylysine aldehyde-derived collagen cross-links.

Shetty S, Sharma M, Kabekkodu S, Kumar N, Satyamoorthy K, Radhakrishnan R J Carcinog. 2021; 20:9.

PMID: 34526855 PMC: 8411980. DOI: 10.4103/jcar.JCar_24_20.


Effect of Lysyl Oxidase G473 A Polymorphism on Lysyl Oxidase and Total Soluble Collagen Expression in Oral Submucous Fibrosis.

Mukherjee S, Katarkar A, Dhariwal R, Mohanty S, Mahato B, Ray J Asian Pac J Cancer Prev. 2021; 22(8):2493-2499.

PMID: 34452563 PMC: 8629460. DOI: 10.31557/APJCP.2021.22.8.2493.


Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis.

Cheng R, Wang Y, Yu-Fong Chang J, Pan Y, Chang M, Jeng J Int J Mol Sci. 2020; 21(21).

PMID: 33143101 PMC: 7663238. DOI: 10.3390/ijms21218104.

References
1.
Shieh T, Lin S, Liu C, Chang S, Ku T, Chang K . Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis. Clin Cancer Res. 2007; 13(15 Pt 1):4378-85. DOI: 10.1158/1078-0432.CCR-06-2685. View

2.
Shieh T, Tu H, Ku T, Chang S, Chang K, Liu C . Association between lysyl oxidase polymorphisms and oral submucous fibrosis in older male areca chewers. J Oral Pathol Med. 2008; 38(1):109-13. DOI: 10.1111/j.1600-0714.2008.00695.x. View

3.
Trivedy C, Warnakulasuriya K, Peters T, Senkus R, Hazarey V, Johnson N . Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med. 2000; 29(6):241-8. DOI: 10.1034/j.1600-0714.2000.290601.x. View

4.
Rucker R, Kosonen T, Clegg M, Mitchell A, Rucker B, Keen C . Copper, lysyl oxidase, and extracellular matrix protein cross-linking. Am J Clin Nutr. 1998; 67(5 Suppl):996S-1002S. DOI: 10.1093/ajcn/67.5.996S. View

5.
Rajalalitha P, Vali S . Molecular pathogenesis of oral submucous fibrosis--a collagen metabolic disorder. J Oral Pathol Med. 2005; 34(6):321-8. DOI: 10.1111/j.1600-0714.2005.00325.x. View